To conclude on the clinical application of this study, OSCC patients with observed low ACAT1 expression in their tumour compared to the pre-tumour tissue may respond better to ketogenic diet therapy, although further investigations of BDH1, BDH2 and OXCT1 related to the ketolysis would be required. The gene discussed is ACAT1; the disease is neoplasm.